Breaking News

Boehringer Selects Certara’s Drug Discovery Platform

Provides shared discovery data across global working groups

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Boehringer Ingelheim has selected Certara’s D360 as its global drug discovery platform. D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. It will allow Boehringer to share discovery data across global working groups, including external collaborators. Boehringer plans to install the global data mining tool at three sites, Ridgefield, CT, Biberach, Germany, and Vienna, Austria.   “In addition to integrating data for easy access, D360 e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters